---
title: Molecular subtyping of acute myeloid leukemia through ferroptosis signatures
  predicts prognosis and deciphers the immune microenvironment
date: '2023-09-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37691822/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20230911181154&v=2.17.9.post6+86293ac
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Acute myeloid leukemia (AML) is one of the most aggressive hematological
  malignancies with a low 5-year survival rate and high rate of relapse. Developing
  more efficient therapies is an urgent need for AML treatment. Accumulating evidence
  showed that ferroptosis, an iron-dependent form of programmed cell death, is closely
  correlated with cancer initiation and clinical outcome through reshaping the tumor
  microenvironment. However, understanding of AML heterogeneity based on extensive
  profiling ...
disable_comments: true
---
Acute myeloid leukemia (AML) is one of the most aggressive hematological malignancies with a low 5-year survival rate and high rate of relapse. Developing more efficient therapies is an urgent need for AML treatment. Accumulating evidence showed that ferroptosis, an iron-dependent form of programmed cell death, is closely correlated with cancer initiation and clinical outcome through reshaping the tumor microenvironment. However, understanding of AML heterogeneity based on extensive profiling ...